Americans at high risk of getting Covid-19 will be able to receive one of three booster shots vaccination After regulatory approval for so-called mixed-and-match administration, it was approved for use in the United States.
The U.S. Food and Drug Administration announced on Wednesday that it has approved both. Modana When Johnson & Johnson To provide vaccine booster shots to people over the age of 65, or young adults at high risk of being infected with Covid due to health or work. This decision will be made one month after the FDA has done the same for the BioNTech / Pfizer vaccine.
Regulators added that they would be allowed to receive any of the three allowed shots, regardless of the shots they received on the first course.
This decision could pave the way for other countries to follow, and in countries that primarily used viral vector shots, such as those made by Oxford / AstraZeneca, sought demand for Pfizer and Modana messenger RNA vaccines. It can increase dramatically.
Janet Woodcock, Deputy Head of the FDA, said in a statement: The availability of these licensed boosters is important for continued protection against Covid-19 disease. “
The decision to allow a “mix and match” booster strategy could benefit people who have blended vaccinations from better protection against the coronavirus, following the announcement of a study to the FDA Expert Advisory Board last week. I showed that there is. This was especially true for those who were the first to receive a Johnson & Johnson one-shot jab. Experts have found that they believe that they will encourage many to choose the mRNA vaccine for booster doses.
J & J said it welcomed the decision to approve the use of booster jabs and other vaccines as part of its “mix and match” strategy.
Paul Stoffels, Chief Scientific of J & J, said: board member.
The Biden administration’s rollout of booster doses has been delayed by lines within the government over whether they are really needed.
President Joe Biden Said in august The booster dose will be generally available by September 20, but after a committee of experts recommended that the FDA approve boosters only for at-risk populations, those plans It was shelved.
Within the FDA, there was also a backlash against the idea of a broad booster campaign by two extroverted scientists from the regulatory agency. Publicly criticize idea.
However, Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said Wednesday that authorities are still actively pursuing the idea of making boosters more widely available.
He said in a statement: .. “
Additional report by Jamie Smith in New York
Road to recovery
What you need to know about post-pandemic business and economy. sign up. Sign up here
FDA gives a green light to booster shots of Moderna and Johnson & Johnson Covid
Source link FDA gives a green light to booster shots of Moderna and Johnson & Johnson Covid